ASX BRIEFS

261 Episodes

Reverse

EPIMINDER LTD (ASX:EPI) - A New Standard For Epilepsy Monitoring

2026-11-0806:33

Send us Fan Mail ASX Investment Opportunity - Epiminder Ltd (ASX:EPI) Seizure diaries ask people to remember the hardest moments of their lives, then clinicians are expected to make high-stakes treatment calls off that memory. That’s the gap Epiminder Limited wants to close, and we’re joined by CEO Rohan Hoare to explain how continuous long-term EEG monitoring could push epilepsy care towards objective evidence rather than best guesses. Rohan breaks down what Epiminder actually builds...

SENSEN NETWORKS LTD (ASX:SNS) - How Councils Use Cameras And Sensors To Automate Street Work

2026-11-0213:02

Send us Fan Mail ASX Investment Opportunity - SenSen Networks Ltd (ASX:SNS) City streets generate endless problems that still get handled the old way: clipboards, call-outs, manual counts, and delayed reporting. We talk with Dr Subhash Challa, CEO of SenSen Networks, about a different approach: physical AI that uses cameras and sensors to automate labour-intensive city council monitoring in real time, turning everyday street activity into data councils can act on quickly. We break down the ...

KGL RESOURCES LTD (ASX:KGL) - How KGL Moves Jervois From Plan To Construction

2026-10-2711:36

Send us Fan Mail ASX Investment Opportunity - KGL Resources Ltd (ASX:KGL) A mining project can look great on paper and still fail on the basics: funding, timing, and execution. We sit down with Sam Strohmayr, CEO of KGL Resources, to unpack how the Jervois copper project in the Northern Territory moves past the point of promise and into real construction, with first copper concentrate targeted for early 2028. We talk through the board’s Final Investment Decision and what had to be in place ...

VECTUS BIOSYSTEMS LTD (ASX:VBS) - A Drug That May Reverse Lung Scarring

2026-10-2016:10

Send us Fan Mail ASX Investment Opportunity - Vectus Biosystems Ltd (ASX:VBS) Lung scarring that won’t stop, treatments that mostly slow the slide, and a median survival often measured in years, not decades, is why idiopathic pulmonary fibrosis (IPF) is one of the most urgent targets in respiratory medicine. We’re joined by Dr Tara Speranza, CEO and CTO of Vectus Biosystems, to explain why the company is putting VB0004 forward as its lead program and why the preclinical signals suggesting fib...

OVERWATCH TECHNOLOGIES LTD (ASX:OWL) - How Overwatch Turns Drones Into Maritime Intelligence

2026-10-1612:18

Send us Fan Mail ASX Investment Opportunity - Overwatch Technologies Ltd (ASX:OWL) Australia and the Indo-Pacific are dealing with a hard truth: our oceans are vast, threats move fast, and traditional maritime surveillance is expensive to scale. We sit down with Oscar Leslie, Managing Director and co-founder of Overwatch Technologies Limited, to dig into how modern maritime domain awareness can be built with autonomous systems, AI-enabled surveillance, and smart sensor networks that spot wha...

#box-pro-ellipsis-179449126235757{-webkit-line-clamp:2;}ASX BRIEFS